SAN FRANCISCO, June 6, 2017 /PRNewswire/ -- Nektar
Therapeutics (Nasdaq: NKTR) announced today that its corporate
presentation will be webcast at the upcoming Jefferies 2017 Global
Healthcare Conference in New York
City on Wednesday, June 7,
2017 at 9:30 a.m. Eastern
time.
The presentation will be accessible via a Webcast through a link
posted on the Investors, Events Calendar section of the Nektar
website: http://ir.nektar.com/events.cfm. This Webcast will be
available for replay until July 10,
2017.
About Nektar
Nektar Therapeutics is a research-based development stage
biopharmaceutical company whose mission is to discover and develop
innovative medicines to address the unmet medical needs of
patients. Our R&D pipeline of new investigational medicines
includes treatments for cancer, auto-immune disease and chronic
pain. We leverage Nektar's proprietary and proven chemistry
platform in the discovery and design of our new therapeutic
candidates. Nektar is headquartered in San Francisco,
California, with additional
operations in Huntsville, Alabama and Hyderabad,
India. Further information about
the company and its drug development programs and capabilities may
be found online at http://www.nektar.com.
Contact:
Investors
Jennifer Ruddock of Nektar Therapeutics
415-482-5585
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nektar-to-webcast-presentation-at-jefferies-2017-global-healthcare-conference-in-new-york-city-300469746.html
SOURCE Nektar Therapeutics